Heart Palpitations That Modern Medicine Calls “Benign”
Palpitations are a common reason for primary-care consultation, and many people are reassured after history, examination, ECG, ambulatory monitoring, and echocardiography show no dangerous rhythm disorder or structural heart disease. For some patients, that reassurance is enough. For others, the sensations continue: a skipped beat, a flutter, a thud in the chest, or a brief racing episode that is medically low-risk but still distressing.
Pushkarmool heart-palpitation research sits at the intersection of classical Ayurvedic chest-respiratory medicine and modern cardiovascular pharmacology. This review examines Pushkarmool (Inula racemosa) and companion herbs such as Arjuna, Brahmi, Ashwagandha, and supervised Sarpagandha in the context of functional palpitations, stress-linked cardiac awareness, and mild autonomic imbalance after appropriate medical evaluation. These herbs are not substitutes for diagnosing or treating clinically significant arrhythmia.
Critical Safety Preface
Palpitations with chest pain, fainting, near-fainting, severe breathlessness, new neurological symptoms, a sustained very fast or irregular pulse, pregnancy, known heart disease, a pacemaker, previous cardiac event, or use of antiarrhythmic, anticoagulant, beta-blocker, calcium-channel-blocker, digoxin, or blood-pressure medication require medical evaluation before any herbal regimen. The herbs discussed here belong in practitioner-guided supportive care for appropriately evaluated functional palpitations, not in emergency rhythm management.
Pushkarmool (Inula racemosa): Classical and Pharmacological Profile
Pushkara or Pushkarmool is the dried root of Inula racemosa Hook. f., described in the Ayurvedic Pharmacopoeia of India as a stout herb found in the Western Himalayas up to about 2600 metres. Its rasa is katu and tikta, its guna is laghu, its virya is ushna, its vipaka is katu, and its karma is kaphavatajit. The pharmacopoeial therapeutic uses include hikka, kasa, svasa, parsvasula, aruchi, adhmana, jvara, sopha, ardita, and pandu, with a powder dose of 1-3 g.
This classical profile explains why Pushkarmool is traditionally valued in chest presentations where breath, cough, side pain, tightness, kapha obstruction, and vata movement are prominent. Classical discussions of Pushkara place it with herbs used for shvasa and hikka, and it is repeatedly described in relation to hikka, shvasa, kasa, and parshvashula. In a palpitation protocol, this does not make Pushkarmool a generic “heart sedative”; it makes it a chest-focused, vata-kapha-addressing herb that should be selected according to presentation.
The Ayurvedic Pharmacopoeia lists essential oil as a constituent of Pushkara. Modern phytochemical reviews of Inula racemosa root describe sesquiterpene lactones including alantolactone and isoalantolactone, along with related lactones. Preclinical cardiovascular work includes hydroalcoholic root extract in isoproterenol-induced myocardial injury models and isolated heart preparations in which root constituents showed negative chronotropic and negative inotropic actions. For functional palpitations, this supports a cautious, practitioner-guided role after medical screening rather than unsupervised use for any fast or irregular heartbeat.
Companion Herbs in a Cardiac Support Protocol
The Ayurvedic approach to functional palpitations is not a fixed stack of capsules. The herb choice depends on whether the dominant picture is chest tightness and breath discomfort, cardiac weakness, anxiety-driven awareness of heartbeat, chronic stress and sleep depletion, or a more forceful sympathetic state that requires physician-level supervision.
Arjuna (Terminalia arjuna) is the dried stem bark of Terminalia arjuna. In the Ayurvedic Pharmacopoeia of India it is described with kashaya rasa, ruksha guna, shita virya, katu vipaka, and hridya karma, with hrdroga included among its therapeutic uses. Its pharmacopoeial powder dose is 3-6 g. Human cardiovascular trials and reviews mainly concern angina, chronic stable angina, and chronic heart-failure adjunct care; therefore, Arjuna is best framed as a classical cardiotonic support herb rather than a stand-alone treatment for palpitations.
Brahmi (Bacopa monnieri) is useful when palpitations and anxious cardiac awareness reinforce one another. The Ayurvedic Pharmacopoeia describes Brahmi as medhya, rasayana, vatahara, and kaphahara, with manasavikara among its therapeutic uses and a powder dose of 1-3 g. Clinical work with standardized Bacopa extracts has included nervous-system and anxiety-related outcomes, making Brahmi a reasonable practitioner-selected companion when the palpitation experience is tied to worry, over-alertness, and mental fatigue.
Ashwagandha (Withania somnifera) belongs more to the stress-resilience side of the protocol than to direct rhythm management. The Ayurvedic Pharmacopoeia describes the root as rasayana, balya, vajikarana, and vatakaphapaha, with alkaloids and withanolides listed among its constituents. Stress trials commonly use standardized root extracts, while the pharmacopoeial powder dose is 3-6 g. It should be avoided or used only with medical guidance in pregnancy, thyroid disorders, liver disease, autoimmune disease, sedative use, and complex medication regimens.
Sarpagandha (Rauwolfia serpentina) represents the high-potency end of the Ayurvedic cardiac-autonomic spectrum. The Ayurvedic Pharmacopoeia describes Sarpagandha root with indole alkaloids and includes reserpine as an identifying marker. Reserpine depletes catecholamine storage, which is why Rauwolfia-derived pharmacology became important in antihypertensive drug history. Because of risks such as depression, sedation, hypotension, bradycardia, and multiple drug interactions, Sarpagandha is not a home-use supplement for palpitations and should be used only under qualified clinical supervision.
| Herb | Best-Fit Role | Evidence Context | Traditional / Studied Dose Context | Key Cautions |
|---|---|---|---|---|
| Pushkarmool | Vata-kapha chest presentations with breath, cough, side pain, or tightness | Ayurvedic Pharmacopoeia plus preclinical cardiovascular data | API powder dose: 1-3 g | Avoid self-use with diagnosed arrhythmia, cardiac medicines, pregnancy, or structural heart disease |
| Arjuna | Classical cardiotonic support | Ayurvedic Pharmacopoeia plus small human cardiovascular trials and reviews | API powder dose: 3-6 g; extract dosing is product-specific | Use with clinician review in heart disease or when taking cardiac, blood-pressure, or anticoagulant medicines |
| Brahmi | Anxious heartbeat awareness, mental over-alertness, stress-linked symptoms | Ayurvedic Pharmacopoeia plus human nervous-system trials | API powder dose: 1-3 g; standardized extracts commonly use product-specific dosing | Review use with sedatives, thyroid medication, neurological medication, or pregnancy |
| Ashwagandha | Stress load, poor sleep, fatigue, vata depletion | Ayurvedic Pharmacopoeia plus human stress trials | API powder dose: 3-6 g; extract trials often use standardized root extracts | Avoid or supervise in pregnancy, thyroid disease, liver disease, autoimmune disease, and sedative use |
| Sarpagandha | High-potency autonomic and blood-pressure medicine under supervision | Ayurvedic Pharmacopoeia plus reserpine pharmacology | Supervised use only | Depression, sedation, hypotension, bradycardia, pregnancy risk, and multiple interactions |
The Vagal Tone Approach: Pranayama for Functional Palpitations
The vagus nerve is a major parasympathetic regulator of heart rate, and heart-rate variability is commonly used as a marker of autonomic balance. Slow breathing and pranayama practices can influence heart rate and heart-rate variability, making them useful supportive practices when palpitations have been medically evaluated and are linked with stress, over-arousal, or anxious body scanning.
Brahmari pranayama is a practical choice because it is gentle, non-straining, and naturally lengthens exhalation through humming. A conservative protocol is 5-10 minutes once or twice daily, seated comfortably, without breath retention or force. Stop the practice and seek medical advice if it causes dizziness, chest pain, marked breathlessness, or a sustained racing rhythm. Technique details can be paired with the broader guide to pranayama breathing techniques for stress.
Lifestyle Triggers to Address
Functional palpitation care works best when obvious triggers are corrected. Common triggers include caffeine, alcohol, stimulant-containing cold medicines, energy drinks, anxiety or panic, skipped meals, low blood sugar, dehydration, anemia, thyroid imbalance, electrolyte disturbance, and sleep debt. A symptom diary that records pulse, timing, food, caffeine, sleep, stress, and menstrual or exertional context often reveals the pattern more clearly than memory alone.
Magnesium and potassium are important for normal neuromuscular and cardiac electrical function, but supplementation should be individualized. People with kidney disease, those taking diuretics, ACE inhibitors, ARBs, digoxin, antiarrhythmics, or blood-pressure medicines should not self-prescribe electrolyte supplements for palpitations. A safer first step is to discuss CBC, thyroid profile, electrolytes, and magnesium status with a healthcare provider when palpitations persist.
Putting the Ayurvedic Protocol Together
A conservative Ayurvedic sequence begins with medical evaluation, then trigger correction, sleep restoration, regular meals, hydration, and gentle pranayama. Herbs are then selected according to the person: Pushkarmool when the chest-respiratory vata-kapha picture fits, Arjuna when classical cardiac support is appropriate, Brahmi when anxious awareness is central, Ashwagandha when stress depletion and poor sleep dominate, and Sarpagandha only when a qualified clinician decides its potency is justified.
This is the most balanced role for Pushkarmool in functional palpitations: not a replacement for ECG-based diagnosis, not an emergency rhythm medicine, and not a universal supplement, but a classical chest-focused herb with relevant preclinical cardiovascular pharmacology that may belong in a carefully selected, practitioner-guided plan.
Disclaimer: This article is for educational purposes only and does not replace professional medical advice. Consult a qualified Ayurvedic practitioner, cardiologist, or healthcare provider before starting any herb, supplement, or breathing protocol for palpitations.
References
- Approach to palpitations in primary care (2024), PubMed Central
- Www1 (www1.racgp.org.au)
- Mayoclinic (mayoclinic.org)
- Healthdirect (healthdirect.gov.au)
- Ayurvedic Pharmacopoeia of India
- Jaims (jaims.in)
- Jacsdirectory (jacsdirectory.com)
- Effect of Inula racemosa root extract on cardiac function and oxidative stress against isoproterenol-induced myocardial infarction (2011), PubMed
- Ayurvedic Pharmacopoeia of India
- Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis (2014), PubMed Central
- Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial (2016), PubMed
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial (2008), PubMed Central
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract (2014), PubMed
- Ayurvedic Pharmacopoeia of India
- A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults (2012), PubMed Central
- NIH Office of Dietary Supplements
- Ayurvedic Pharmacopoeia of India
- Go (go.drugbank.com)
- Inchem (inchem.org)
- Investigating components of pranayama for effects on heart rate variability (2021), PubMed Central
- Research (research.leedstrinity.ac.uk)
- NIH Office of Dietary Supplements
The Vataja Hrid Roga framing for vagally-mediated palpitations makes sense. The Vata-pacifying approach through Pushkarmool and Arjuna combination feels clinically appropriate.
The clinical study you cite is that the AIIMS Rishikesh trial from 2023? If so the sample was small (n=32). Any larger replications?
Is there any cardiac electrophysiology concern with high-dose Pushkarmool? Some alkaloids affect ion channels.
The article says 3-6g dose. Is that dry root powder or extract? And is it split across 2-3 doses?
Can Pushkarmool be combined with Arjuna Ksheer Pak or should they be taken separately?
the evidence quality for Pushkarmool and cardiac arrhythmia is preliminary at best. I cant recommend this to patients over evidence-based antiarrhythmics.
i tried Pushkarmool for 3 months for my palpitations and saw no change in symptom frequency or severity.
Pushkarmool in Chyawanprash form has been part of my protocol for ectopic beats for 6 months. PVC frequency down from roughly 3000/day to under 1000/day on Holter.
For palpitations associated with hyperthyroidism rather than idiopathic causes, does the Pushkarmool approach still apply?
Useful info.
Finally an article with actual published research on Pushkarmool rather than just classical text reference. नमस्ते
The discussion of pushkarmool’s calcium channel antagonist activity helped me understand why it might ease palpitations.
that’s a good point, the dosage question is something I also asked my vaidya about.
That’s a fair general point, though if you actually read the article it does say cardiac causes should be ruled out first before considering Pushkarmool. The whole premise is patients who’ve already been through the cardiology workup and come back clear.
The clinical study you cite is that thr AIIMS Rishikesh trial from 2023? If so the sample was small (n=32). Any larger replications?
Will try this.
After reading about the Brahmari pranayama study I tried the humming breath for a few days and noticed my heart rate felt steadier.
@Ashok makes sense given what the article says about the Pitta component.
Good to know.
Although the evidence for pushkarmool is still preliminary the animal study results are intriguing enough to warrant further human trials.
The evidence quality for Pushkarmool and cardiac arrhythmia is preliminary at best. I can’t recommend this to patients over evidence-based antiarrhythmics.
Finally an article wiht actual published research on Pushkarmool rather than just classical text reference.
Can Pushkarmool be combined with Arjuna Ksheer Pak or should they be taken separately? ❤️
makes sense given what the article says about the Pitta component.
One point that stood out was the safety note about avoiding pushkarmool if you’re already on calcium channel blockers.